Posted On: 11/29/2016 8:36:51 AM
Post# of 23083

CYTR: NEWS...CytRx Reports Statistically Significant Updated Results from Pivotal Phase 3 Trial of Aldoxorubicin in Patients with Second-Line Soft Tissue Sarcomas


Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.